(RTTNews) - Verona Pharma plc (VRNA), Friday announced some strategic changes in its capital structure, increasing the company's financial flexibility ... term loan facility to $450 million ...

RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc ... and amend our term loan facility with Oaktree and OMERS, increasing our financial flexibility and simplifying ...

RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) ...

Singota Solutions has opened a new facility in Balerna, Switzerland, offering a location touching extensive European ...

On November 28, Changzhou Qianhong Bio-pharma Co., Ltd. started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District (CND). With an investment of ...

BridgeBio Pharma ... the term debt facility significantly lowers interest expenses and eliminates near-term amortization payments, enhancing the company's financial flexibility.

To learn more about the new sterile injectable manufacturing capabilities at Halo Pharma’s Whippany, NJ facility, please see Noramco Group executives at DCAT Week (March 17-20, 2025) in New York ...

The facility is located at 330 Wyckoff Mills Road ... company Rising Pharmaceuticals to join the many other high-tech pharma and life science companies that have chosen to make East Windsor ...

Orchid Pharma’s Alathur facility remains India’s only U.S. FDA-approved manufacturing site for sterile cephalosporins, a class of antibiotics used to treat bacterial infections. “As India's ...